newsfilter
← Latest News
GlobeNewswire·

BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026

  • BrainsWay Ltd. will report third quarter 2026 financial results & operational highlights before U.S. market open on Tuesday, November 10, 2026.
  • The Company will host an English conference call & webcast at 8:30 AM Eastern Time on November 10, 2026, with dial-in numbers 1-877-269-7751 (U.S.) & 1-201-389-0908 (International) & Conference ID 13763521.
  • A Hebrew version of the conference call will occur on Wednesday, November 11, 2026, at 11:00 AM Israeli Daylight Time.
  • The English webcast will be available for replay for 30 days at investors.brainsway.com/events-and-presentations/event-calendar.
  • BrainsWay utilizes its proprietary Deep TMS™ platform to treat major depressive disorder, obsessive-compulsive disorder, & smoking addiction with three FDA-cleared indications.
  • Founded in 2003, BrainsWay operates in the United States & Israel while conducting additional clinical trials for psychiatric, neurological, & addiction disorders.
  • Ido Marom serves as Chief Financial Officer for BrainsWay, while Jeff Warren of LifeSci Advisors handles investor relations.